A detailed history of Engineers Gate Manager LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 73,968 shares of ADMA stock, worth $1.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
73,968
Previous 39,420 87.64%
Holding current value
$1.46 Million
Previous $260,000 217.69%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $206,597 - $386,246
34,548 Added 87.64%
73,968 $826,000
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $173,448 - $265,690
39,420 New
39,420 $260,000
Q2 2021

Aug 16, 2021

SELL
$1.51 - $2.07 $51,596 - $70,731
-34,170 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.67 - $2.95 $29,392 - $51,920
-17,600 Reduced 34.0%
34,170 $60,000
Q4 2020

Feb 16, 2021

SELL
$1.8 - $2.56 $900 - $1,280
-500 Reduced 0.96%
51,770 $101,000
Q3 2020

Nov 16, 2020

BUY
$2.04 - $3.74 $106,630 - $195,489
52,270 New
52,270 $125,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.88B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.